CLDX Competitors & Alternatives
Compare Celldex Therapeutics Inc with similar stocks in the same industry
Biotechnology
CLDX
Main Stock$29.37
Tradestie Score
61
Market Cap
$1.68B
Revenue Growth
-1.0%
Analyst Upside
+114.7%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$24.84
|
$2.44B | - | 62 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$70.50
|
$2.42B | - | 64 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$153.18
|
$2.41B | - | 71 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$35.47
|
$2.40B | - | 65 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 52 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$31.87
|
$2.37B | 142.7 | 48 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$135.07
|
$2.35B | - | 54 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$8.64
|
$2.34B | - | 39 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$76.00
|
$2.33B | - | 40 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$37.18
|
$2.33B | - | 45 | Compare |
More CLDX Analysis
Data updated: Oct 21, 2026 | Industry: Biotechnology (SIC 2835)
220 stocks in this industry